🔗 Permalink

Inventor profile of:

Michael Logan

City:

Edmonton

Country:

Canada

Published Applications:

Last publication date:

2025-11-06

Top Assignees for applications by Michael Logan

The entities that hold a legal rights for patent applications filed by inventor Logan Michael:

THE GOVERNORS OF THE UNIVERSITY OF ALBERTA 11 Edmonton, Canada
Helmholtz Center for Infection Research 2 Braunschweig, Germany
THE GOVERNORS OF THE UNIVERSITY OF ALBERTA 1 Edmonton, Alberta, Canada
The Governors of the University of Alberta 1 Edmonton, AB Canada

Recent patent applications by Logan Michael

Michael Logan from Edmonton, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-11-06

US20250339513A1

Human necessities

HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF

#2 | 2025-05-01

US20250136643A1

Chemistry; metallurgy

HEPATITIS C VIRUS E1/E2 HETERODIMERS AND METHODS OF PRODUCING SAME

#3 | 2024-12-05

US20240398938A1

Human necessities

Hepatitis C Virus Peptide Compositions and Methods of Use Thereof

#4 | 2024-09-26

US20240316186A1

Human necessities

E1E2 HCV VACCINES AND METHODS OF USE

#5 | 2024-02-22

US20240058438A1

Human necessities

Hepatitis C virus immunogenic compositions and methods of use thereof

#6 | 2023-10-05

US20230310590A1

Human necessities

Hepatitis C virus immunogenic compositions and methods of use thereof

#7 | 2023-03-30

US20230098265A1

Human necessities

E1E2 HCV VACCINES AND METHODS OF USE

#8 | 2022-04-07

US20220105175A1

Human necessities

Hepatitis C virus immunogenic compositions and methods of use thereof

#9 | 2022-02-10

US20220041661A1

Chemistry; metallurgy

Hepatitis c virus E1/E2 heterodimers and methods of producing same

#10 | 2021-06-10

US20210170018A1

Human necessities

Hepatitis C virus immunogenic compositions and methods of use thereof

#11 | 2021-05-20

US20210145963A9

Human necessities

E1E2 HCV VACCINES AND METHODS OF USE

#12 | 2021-04-08

US20210100895A1

Human necessities

Hepatitis C virus immunogenic compositions and methods of use thereof

#13 | 2021-02-25

US20210052721A1

Human necessities

Hepatitis C virus peptide compositions and methods of use thereof

#14 | 2019-08-01

US20190231867A1

Human necessities

Hepatitis C virus immunogenic compositions and methods of use thereof

#15 | 2019-07-25

US20190224308A1

Human necessities

Hepatitis C virus immunogenic compositions and methods of use thereof

#16 | 2019-07-11

US20190209677A1

Human necessities

Hepatitis c virus immunogenic compositions and methods of use thereof

#17 | 2018-10-04

US20180282377A1

Chemistry; metallurgy

Hepatitis C virus E1/E2 heterodimers and methods of producing same

#18 | 2018-06-21

US20180169219A1

Human necessities

Hepatitis C virus immunogenic compositions and methods of use thereof

#19 | 2016-03-10

US20160067332A1

Human necessities

E1E2 HCV VACCINES AND METHODS OF USE

InventorID:

1465777 ⎘